45.00
2.00%
-0.92
시간 외 거래:
45.00
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals (NASDAQ:CRBP) Lifted to "Hold" at StockNews.com - MarketBeat
MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) Raised to Hold at StockNews.com - Defense World
Defense World
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
MarketWatch
Attention Biotech Investors - Stocks To Watch - Agios Pharmaceuticals (NASDAQ:AGIO), Corbus Pharmaceutica - Benzinga
Benzinga
Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference - Corbus Pharmaceutic - Benzinga
Benzinga
Where are the Opportunities in (CRBP) - Stock Traders Daily
Stock Traders Daily
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
MarketWatch
Royal Bank of Canada Initiates Coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) - Defense World
Defense World
Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
MarketWatch
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Wei - Benzinga
Benzinga
Corbus Pharmaceuticals (NASDAQ:CRBP) Receives New Coverage from Analysts at Royal Bank of Canada - MarketBeat
MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets - Seeking Alpha
Seeking Alpha
StockNews.com Lowers Corbus Pharmaceuticals (NASDAQ:CRBP) to Sell - Defense World
Defense World
Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint - Yahoo News UK
Yahoo News UK
Oppenheimer Raises Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $60.00 - Defense World
Defense World
Corbus Pharmaceuticals: 2Q Earnings Snapshot - Yahoo News UK
Yahoo News UK
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 11% last week - Simply Wall St
Simply Wall St
How Much Of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Do Insiders Own? - Yahoo Movies UK
Yahoo Movies UK
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference - Yahoo Finance
Yahoo Finance
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer - MarketBeat
MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer - MarketBeat
MarketBeat
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswire
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
MarketWatch
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Yahoo Finance
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK
Yahoo Movies UK
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK
Yahoo Movies UK
Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint - Yahoo Singapore News
Yahoo Singapore News
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum - GlobeNewswire
GlobeNewswire
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum - Yahoo Finance
Yahoo Finance
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire Inc.
Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength
Zacks Investment Research
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
MarketWatch
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC - Yahoo Finance
Yahoo Finance
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
MarketWatch
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
Zacks Investment Research
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Corbus Pharmaceuticals: Q4 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
MarketWatch
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit - GlobeNewswire
GlobeNewswire
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
MarketWatch
자본화:
|
볼륨(24시간):